Pulmatrix Correlations

PULM Stock  USD 4.78  0.05  1.04%   
The current 90-days correlation between Pulmatrix and Edesa Biotech is 0.2 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pulmatrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pulmatrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Pulmatrix Correlation With Market

Modest diversification

The correlation between Pulmatrix and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Moving against Pulmatrix Stock

  0.35CAPLIPOINT Caplin Point LaboratoriesPairCorr
  0.32002262 Jiangsu Nhwa PharmacPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DAREEDSA
NERVNXTC
ANLEDSA
LPCNDARE
ANLFBLG
LPCNEDSA
  

High negative correlations

NXTCFBLG
NERVFBLG
ANLNXTC
LPCNPTHS
NERVANL
FBLGPTHS

Risk-Adjusted Indicators

There is a big difference between Pulmatrix Stock performing well and Pulmatrix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pulmatrix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EDSA  2.98 (0.43) 0.00 (0.30) 0.00 
 7.00 
 30.37 
PTHS  4.04  0.95  0.20  0.56  4.45 
 13.96 
 36.92 
FBLG  4.05 (0.80) 0.00 (0.20) 0.00 
 8.77 
 28.59 
DARE  2.27 (0.40) 0.00 (0.26) 0.00 
 3.88 
 12.01 
NXTC  4.29  1.20  0.18  1.82  5.41 
 11.75 
 60.54 
ASBP  8.16  0.71  0.07  0.75  8.60 
 11.11 
 111.36 
ANL  2.48  0.00 (0.01) 0.09  3.11 
 6.51 
 15.85 
LEXX  4.98  0.81  0.07 (0.43) 7.36 
 11.22 
 64.28 
LPCN  1.96 (0.25) 0.00 (0.22) 0.00 
 4.04 
 12.94 
NERV  6.90  1.80  0.38  0.49  4.14 
 8.44 
 157.05 

Pulmatrix Corporate Management